Gilead, Kite to Acquire Cell Design Labs for Up-to-$567M, Growing CAR-T Footprint – Genetic Engineering & Biotechnology News
FierceBiotech |
Gilead, Kite to Acquire Cell Design Labs for Up-to-$567M, Growing CAR–T Footprint
Genetic Engineering & Biotechnology News Gilead Sciences and its Kite cell therapy subsidiary have agreed to acquire Cell Design Labs for up to approximately $567 million, in a deal designed to grow the buyers' footprint in chimeric antigen receptor T cell (CAR-T) and other cellular therapies … Gilead deepens CAR–T push with deal for Cell Design Gilead makes bolt-on CAR–T buy after Kite deal Gilead swoops in with $567M deal to buy CAR-T 2.0 player Cell … |
